KENNEWICK, Wash., March 13, 2007 (PRIME NEWSWIRE) -- Advanced Medical Isotopes Corporation (AMIC) (Pink Sheets:ADMD) of Kennewick, Washington announces its plans to commission a facility for the production of radiopharmaceuticals used in Positron Emission Tomography (PET) imaging applications, as well as many other important diagnostic and therapeutic medical isotopes. Operations will commence in Q3 of 2007 with the installation of a cost-effective proton linear accelerator (linac) purchased from AccSys Technology, Inc. (AccSys). This PULSAR(r) PET Isotope Production system, which sets a new standard for production of PET and other isotopes using proton beams, is a more compact and reliable alternative to cyclotrons, incorporating proven compact accelerator technology integrated with high production yield targets and advanced chemistry process units.
According to William J. Stokes, CEO of AMIC, "We are extremely delighted to have the opportunity to work with AccSys to place in our new facility their first commercial PET isotope production system in North America. Our team anticipates that this linac will also be able to efficiently produce many other desperately needed medical isotopes for the diagnosis and treatment of major diseases such as cancer, heart disease and arthritis. Thus not only will AMIC have the ability to be a local supplier of the most common PET isotopes (Fluorine-18, Nitrogen-13, Carbon-11, and Oxygen-15), but this AccSys linac will also enable us to efficiently produce many other longer-lived diagnostic isotopes such as Iodine-123 and Indium-111."
About AccSys Technology, Inc.
AccSys Technology, headquartered in Pleasanton, California, is the world's leading commercial producer of rf ion linacs for medical, industrial and research applications. Founded in 1985, AccSys specializes in the development, production, installation and servicing of compact ion linacs using its patented linac technology. AccSys has produced and installed more than 35 linac systems worldwide and is dedicated to providing the highest quality and most reliable commercial ion linac systems to meet the needs of its customers. For more information on AccSys Technology, Inc., please visit the AccSys website at http://www.accsys.com. AccSys became an affiliate company of Hitachi, Ltd. in 2002.
About Advanced Medical Isotopes Corporation
Advanced Medical Isotopes Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers. For more information, please visit www.advancedmedicalisotopes.com
Forward-Looking Statements
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.